Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_provenance.
- NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_assertion description "[The decreased expression of beta(2)-adrenergic receptors (beta(2)-R) on lymphatic cells in rheumatic diseases like RA, together with an impaired influence of catecholamines on immune function in these patients, further underlines the concept of a dysfunction of the ANS in rheumatic diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_provenance.
- NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_assertion evidence source_evidence_literature NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_provenance.
- NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_assertion SIO_000772 12114292 NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_provenance.
- NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_assertion wasDerivedFrom befree-20140225 NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_provenance.
- NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_assertion wasGeneratedBy ECO_0000203 NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP749217.RAlxEOQglk3mK6-W_HlIKFG29Kax-H-g0_CyvFoIp0yhU130_provenance.